Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Familial Atypical Multiple Mole-Melanoma clinical trials
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Familial Atypical Multiple Mole-Melanoma: 2 US clinical trials tracked, none currently recruiting.
Familial Atypical Multiple Mole-Melanoma is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is White Plains Hospital, running 1 of these trials.
Enrollment posture brief
Registry condition familial-atypical-multiple-mole-melanoma
OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Familial Atypical Multiple Mole-Melanoma has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Familial Atypical Multiple Mole-Melanoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Familial Atypical Multiple Mole-Melanoma is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
NCT05692596
Pancreatic Cancer Early Detection Program
White Plains Hospital
NCT02206360
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Familial Atypical Multiple Mole-Melanoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Familial Atypical Multiple Mole-Melanoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Familial Atypical Multiple Mole-Melanoma page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Familial Atypical Multiple Mole-Melanoma trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- White Plains Hospital sponsors the most Familial Atypical Multiple Mole-Melanoma trials on record, review their full trial history before evaluating a specific study. See White Plains Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Familial Atypical Multiple Mole-Melanoma condition card totals 2 registered trials; most-linked intervention Data collection; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.